<?xml version="1.0" encoding="UTF-8"?>
<ref id="mdx698-B22">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Rapoport</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chasen</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gridelli</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Safety and efficacy of rolapitant for prevention of CINV after administration of cisplatin-based HEC in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials</article-title>. 
  <source>Lancet Oncol</source>
  <year>2015</year>; 
  <volume>16</volume>(
  <issue>9</issue>): 
  <fpage>1079</fpage>â€“
  <lpage>1089</lpage>.
  <pub-id pub-id-type="pmid">26272769</pub-id>
 </mixed-citation>
</ref>
